Presentation Information

[29-12-am05S]Time to onset of immune-related adverse events with nivolumab–ipilimumab combination therapy versus nivolumab monotherapy using a drug adverse event database

○Midori Nishiguchi1, Satoshi Noda1,2, Yoshito Ikeda1, Shin-ya Morita1 (1. Grad. Sch. Med. Sci., Shiga Univ. of Med. Sci., 2. Coll. Pharm. Sci., Ritsumeikan Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.